Scott Dreyer insider trades: Collegium Pharmaceutical (COLL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | COLL | ↓ Sell | 49,976 | $40.41 | $2.0M | Direct | Mar 5, 2026 (2d) |
| Dec 8, 2025 | COLL | ↓ Sell | 17,600 | $48.17 | $848K | Direct | Dec 10, 2025 (2d) |
| Aug 18, 2025 | COLL | ↓ Sell | 16,389 | $38.21 | $626K | Direct | Aug 20, 2025 (2d) |
| Aug 13, 2025 | COLL | ↓ Sell | 4,861 | $38.03 | $185K | Direct | Aug 15, 2025 (2d) |
| Mar 21, 2025 | COLL | ↓ Sell | 20,808 | $30.03 | $625K | Direct | Mar 24, 2025 (3d) |
| Mar 14, 2025 | COLL | ↓ Sell | 2,255 | $30.00 | $68K | Direct | Mar 18, 2025 (4d) |
| Mar 7, 2025 | COLL | ↓ Sell | 5,643 | $30.00 | $169K | Direct | Mar 10, 2025 (3d) |
| Mar 6, 2025 | COLL | ↓ Sell | 15,387 | $30.00 | $462K | Direct | Mar 13, 2025 (7d) |
| May 24, 2024 | COLL | ↓ Sell | 108,016 | $33.91 | $3.7M | Direct | May 28, 2024 (4d) |
| Feb 26, 2024 | COLL | ↓ Sell | 10,000 | $36.43 | $364K | Direct | Feb 28, 2024 (2d) |
| Jan 16, 2024 | COLL | ↓ Sell | 23,560 | $32.28 | $761K | Direct | Jan 18, 2024 (2d) |
| Mar 1, 2023 | COLL | ↓ Sell | 13,324 | $26.70 | $356K | Direct | Mar 3, 2023 (2d) |
| Jan 9, 2023 | COLL | ↓ Sell | 17,834 | $27.39 | $489K | Direct | Jan 11, 2023 (2d) |
| Feb 18, 2022 | COLL | ↓ Sell | 10,559 | $21.61 | $228K | Direct | Feb 28, 2022 (10d) |
| Dec 15, 2021 | COLL | ↓ Sell | 5,693 | $18.33 | $104K | Direct | Dec 17, 2021 (2d) |
| Feb 11, 2021 | COLL | ↓ Sell | 7,898 | $25.21 | $199K | Direct | Feb 12, 2021 (1d) |
| Jan 15, 2021 | COLL | ↓ Sell | 1,322 | $22.89 | $30K | Direct | Jan 20, 2021 (5d) |
| Jul 13, 2020 | COLL | ↓ Sell | 1,429 | $17.01 | $24K | Direct | Jul 14, 2020 (1d) |
| May 18, 2020 | COLL | ↓ Sell | 8,000 | $24.00 | $192K | Direct | May 20, 2020 (2d) |
| May 13, 2020 | COLL | ↓ Sell | 4,434 | $22.61 | $100K | Direct | May 15, 2020 (2d) |
| Jan 14, 2020 | COLL | ↓ Sell | 1,321 | $23.87 | $32K | Direct | Jan 16, 2020 (2d) |
| Jul 11, 2019 | COLL | ↓ Sell | 2,857 | $12.31 | $35K | Direct | Jul 12, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other COLL insiders
Open-market trades in the last 12 months
About Scott Dreyer's insider trades
Scott Dreyer is EVP & Chief Commercial Officer at Collegium Pharmaceutical (COLL). Since Jul 11, 2019, Scott has reported no open-market purchases and 22 sales worth $11.6M on SEC Form 4. In the last 12 months: 2 sales ($2.9M).
Their filings also include shares withheld for taxes (14 filings), grants and awards (9 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COLL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.